ORKA · Oruka Therapeutics, Inc.

$103.21 -4.76 (-4.40%)

Market Cap

$7.15B

66.21M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-10	—
10-Q	2026-08-10	2026-06-30
8-K	2026-06-04	2026-06-02
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-06-01	2026-05-29
10-Q	2026-05-13	2026-03-31
8-K	2026-04-30	2026-04-27
8-K	2026-04-27	—
DEF 14A	2026-04-17	2026-06-02
10-K	2026-03-12	2025-12-31
8-K	2025-12-11	—
10-Q	2025-11-12	2025-09-30
8-K	2025-09-22	2025-09-17
10-Q	2025-08-11	2025-06-30
8-K	2025-07-01	—
8-K	2025-06-03	2025-06-02
10-Q	2025-05-14	2025-03-31
DEF 14A	2025-04-18	2025-06-02
10-K	2025-03-06	2024-12-31
8-K	2025-02-05	2025-02-04
8-K	2024-12-19	2024-12-17
8-K	2024-11-18	2024-11-14
8-K	2024-11-14	—
10-Q	2024-11-13	2024-09-30
DEF 14A	2024-10-18	2024-11-14
8-K	2024-10-04	2024-10-03
8-K	2024-09-13	2024-09-11
8-K	2024-09-05	2024-08-29
8-K	2024-08-27	2024-08-26
8-K	2024-08-23	2024-08-22
8-K	2024-08-16	—
8-K	2024-08-15	2024-08-14
8-K	2024-08-01	—
10-Q	2024-08-01	2024-06-30
8-K	2024-07-09	2024-07-03
8-K	2024-04-25	—
10-Q	2024-04-25	2024-03-31
8-K	2024-04-23	2024-04-20
8-K	2024-04-04	2024-04-02
8-K	2024-04-03	—
8-K	2024-03-22	2024-03-19
8-K	2024-02-06	2024-02-02
10-K	2024-02-01	2023-12-31
8-K	2024-02-01	—
8-K	2024-01-31	2024-01-30
DEF 14A	2023-12-19	2024-01-30
8-K	2023-12-05	2023-12-04
8-K	2023-12-04	2023-11-29
8-K	2023-10-18	—
10-Q	2023-10-18	2023-09-30

Showing 1–50 of 121 filings

Key facts CIK 907654 CUSIP 687604108 13F (30d) 236 filings 232 filers Visit website Investor relations